Concepedia

Publication | Open Access

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

DOIFull Paper Access

192

Citations

25

References

2019

Year

Hamzah Abu‐Sbeih, Faisal S. Ali, Abdul Rafeh Naqash, Dwight H. Owen, Sandipkumar Patel, Gregory A. Otterson, Kari Kendra, Biagio Ricciuti, Rita Chiari, Andrea De Giglio,
Journal of Clinical Oncology

Abstract

One third of patients who resumed ICI treatment after IMDC experienced recurrent IMDC. Recurrence of IMDC was less frequent after resumption of anti-PD-1/L1 than after resumption of anti-CTLA-4.

References

YearCitations

Page 1